{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T19:56:06Z","timestamp":1767210966687},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s10549-014-3252-8","type":"journal-article","created":{"date-parts":[[2015,1,3]],"date-time":"2015-01-03T16:28:31Z","timestamp":1420302511000},"page":"505-515","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response"],"prefix":"10.1007","volume":"149","author":[{"given":"Louise","family":"Huzell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mia","family":"Persson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Simonsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Markkula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Ingvar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Jernstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,4]]},"reference":[{"key":"3252_CR1","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-08-1005","volume":"18","author":"JM Dolle","year":"2009","unstructured":"Dolle JM, Daling JR, White E, Brinton LA, Doody DR, Porter PL, Malone KE (2009) Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomark Prev 18:1157\u20131166. doi: 10.1158\/1055-9965.EPI-08-1005","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3252_CR2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/jnci\/djr030","volume":"103","author":"AI Phipps","year":"2011","unstructured":"Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Stefanick ML, Vitolins M, Kabat GC, Rohan TE, Li CI (2011) Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 103:470\u2013477. doi: 10.1093\/jnci\/djr030","journal-title":"J Natl Cancer Inst"},{"key":"3252_CR3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/0008-5472.CAN-09-3460","volume":"70","author":"H Ma","year":"2010","unstructured":"Ma H, Wang Y, Sullivan-Halley J, Weiss L, Marchbanks PA, Spirtas R, Ursin G, Burkman RT, Simon MS, Malone KE, Strom BL, McDonald JA, Press MF, Bernstein L (2010) Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women\u2019s contraceptive and reproductive experiences study. Cancer Res 70:575\u2013587. doi: 10.1158\/0008-5472.CAN-09-3460","journal-title":"Cancer Res"},{"key":"3252_CR4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00665969","volume":"30","author":"I Sch\u00f6nborn","year":"1994","unstructured":"Sch\u00f6nborn I, Nischan P, Ebeling K (1994) Oral contraceptive use and the prognosis of breast cancer. Breast Cancer Res Treat 30:283\u2013292","journal-title":"Breast Cancer Res Treat"},{"key":"3252_CR5","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1158\/1055-9965.1558.13.10","volume":"13","author":"MD Althuis","year":"2004","unstructured":"Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME (2004) Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomark Prev 13:1558\u20131568","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3252_CR6","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1158\/1055-9965.EPI-07-0053","volume":"16","author":"KF Trivers","year":"2007","unstructured":"Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Moorman PG, Kaufman JS, Cai J, Porter PL, Brinton LA, Eley JW, Coates RJ (2007) Oral contraceptives and survival in breast cancer patients aged 20 to 54\u00a0years. Cancer Epidemiol Biomark Prev 16:1822\u20131827. doi: 10.1158\/1055-9965.EPI-07-0053","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3252_CR7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1005790531122","volume":"43","author":"LJ Schouten","year":"1997","unstructured":"Schouten LJ, Hupperets PS, Jager JJ, Volovics L, Wils JA, Verbeek AL, Blijham GH (1997) Prognostic significance of etiological risk factors in early breast cancer. Breast Cancer Res Treat 43:217\u2013223","journal-title":"Breast Cancer Res Treat"},{"key":"3252_CR8","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1158\/1055-9965.EPI-11-0022","volume":"20","author":"Y Lu","year":"2011","unstructured":"Lu Y, Ma H, Malone KE, Norman SA, Sullivan-Halley J, Strom BL, Simon MS, Marchbanks PA, McDonald JA, West DW, Henderson KD, Deapen D, Ursin G, Bernstein L (2011) Oral contraceptive use and survival in women with invasive breast cancer. Cancer Epidemiol Biomark Prev 20:1391\u20131397. doi: 10.1158\/1055-9965.EPI-11-0022","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3252_CR9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/01.AOG.0000284446.22251.6e","volume":"110","author":"PA Wingo","year":"2007","unstructured":"Wingo PA, Austin H, Marchbanks PA, Whiteman MK, Hsia J, Mandel MG, Peterson HB, Ory HW (2007) Oral contraceptives and the risk of death from breast cancer. Obstet Gynecol 110:793\u2013800. doi: 10.1097\/01.AOG.0000284446.22251.6e","journal-title":"Obstet Gynecol"},{"key":"3252_CR10","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0959-8049(98)00139-7","volume":"34","author":"W Sauerbrei","year":"1998","unstructured":"Sauerbrei W, Blettner M, Schmoor C, Bojar H, Schumacher M (1998) The effect of oral contraceptive use on the prognosis of node positive breast cancer patients. German Breast Cancer Study Group. Eur J Cancer 34:1348\u20131351","journal-title":"Eur J Cancer"},{"key":"3252_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0010-7824(97)00068-1","volume":"56","author":"G Larsson","year":"1997","unstructured":"Larsson G, Blohm F, Sundell G, Andersch B, Milsom I (1997) A longitudinal study of birth control and pregnancy outcome among women in a Swedish population. Contraception 56:9\u201316","journal-title":"Contraception"},{"key":"3252_CR12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1470-2045(05)70273-4","volume":"6","author":"V Cogliano","year":"2005","unstructured":"Cogliano V, Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi F (2005) Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment. Lancet Oncol 6:552\u2013553","journal-title":"Lancet Oncol"},{"key":"3252_CR13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF02079683","volume":"70","author":"H Sj\u00f6vall","year":"1972","unstructured":"Sj\u00f6vall H (1972) Abortion and contraception in Sweden 1870-1970. Zeitschrift f\u00fcr Rechtsmedizin 70:197\u2013209","journal-title":"Zeitschrift f\u00fcr Rechtsmedizin"},{"key":"3252_CR14","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(86)90166-2","volume":"2","author":"O Meirik","year":"1986","unstructured":"Meirik O, Lund E, Adami HO, Bergstr\u00f6m R, Christoffersen T, Bergsj\u00f6 P (1986) Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway. Lancet 2:650\u2013654","journal-title":"Lancet"},{"key":"3252_CR15","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(80)91550-0","volume":"1","author":"LE Bottiger","year":"1980","unstructured":"Bottiger LE, Boman G, Eklund G, Westerholm B (1980) Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content. Lancet 1:1097\u20131101","journal-title":"Lancet"},{"key":"3252_CR16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/bcr1029","volume":"7","author":"J Russo","year":"2005","unstructured":"Russo J, Moral R, Balogh GA, Mailo D, Russo IH (2005) The protective role of pregnancy in breast cancer. Breast Cancer Res 7:131\u2013142. doi: 10.1186\/bcr1029","journal-title":"Breast cancer research"},{"key":"3252_CR17","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.ejca.2005.03.035","volume":"41","author":"H Jernstr\u00f6m","year":"2005","unstructured":"Jernstr\u00f6m H, Loman N, Johannsson OT, Borg \u00c5, Olsson H (2005) Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing. Eur J Cancer 41:2312\u20132320. doi: 10.1016\/j.ejca.2005.03.035","journal-title":"Eur J Cancer"},{"key":"3252_CR18","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 347:1713\u20131727","journal-title":"Lancet"},{"key":"3252_CR19","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10552-014-0394-2","volume":"25","author":"K Elebro","year":"2014","unstructured":"Elebro K, Butt S, Dorkhan M, Jernstr\u00f6m H, Borgquist S (2014) Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmo Diet and Cancer Cohort. Cancer Causes Control 25:945\u2013957. doi: 10.1007\/s10552-014-0394-2","journal-title":"Cancer Causes Control"},{"key":"3252_CR20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.breast.2012.08.005","volume":"22","author":"FP Turkoz","year":"2013","unstructured":"Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, Arik Z, Babacan T, Ozisik Y, Altundag K (2013) Association between common risk factors and molecular subtypes in breast cancer patients. Breast 22:344\u2013350. doi: 10.1016\/j.breast.2012.08.005","journal-title":"Breast"},{"key":"3252_CR21","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1158\/1055-9965.EPI-13-0944","volume":"23","author":"EF Beaber","year":"2014","unstructured":"Beaber EF, Malone KE, Tang MT, Barlow WE, Porter PL, Daling JR, Li CI (2014) Oral contraceptives and breast cancer risk overall and by molecular subtype among young women. Cancer Epidemiol Biomark Prev 23:755\u2013764. doi: 10.1158\/1055-9965.EPI-13-0944","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3252_CR22","unstructured":"Swedish Breast Cancer Group (2013) Nationella riktlinjer f\u00f6r behandling av br\u00f6stcancer (Swedish National Guidelines for Breast Cancer Treatment). http:\/\/www.swebcg.se . www.swebcg.se\/Files\/Docs\/Nationella_riktlinjer130501.doc . Accessed 24 Sept 2014"},{"key":"3252_CR23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jsbmb.2005.02.004","volume":"93","author":"A Howell","year":"2005","unstructured":"Howell A, Buzdar A (2005) Are aromatase inhibitors superior to antiestrogens? J Steroid Biochem Mol Biol 93:237\u2013247. doi: 10.1016\/j.jsbmb.2005.02.004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3252_CR24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/bcr2837","volume":"13","author":"MM Regan","year":"2011","unstructured":"Regan MM, Pric KN, Giobbie-Hurder A, Thurlimann B, Gelber RD, International Breast Cancer Study G, Group BIGC (2011) Interpreting Breast International Group (BIG) 1\u201398: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer. Breast Cancer Res 13:209. doi: 10.1186\/bcr2837","journal-title":"Breast Cancer Res"},{"key":"3252_CR25","first-page":"343","volume":"30","author":"L Gibson","year":"2009","unstructured":"Gibson L, Lawrence D, Dawson C, Bliss J (2009) Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women. Cochrane Ddatabase Syst Rev 30:343\u2013375","journal-title":"Cochrane Ddatabase Syst Rev"},{"key":"3252_CR26","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/ijc.22104","volume":"119","author":"A Ringberg","year":"2006","unstructured":"Ringberg A, B\u00e5geman E, Rose C, Ingvar C, Jernstr\u00f6m H (2006) Of cup and bra size: reply to a prospective study of breast size and premenopausal breast cancer incidence. Int J Cancer 119:2242\u20132243. doi: 10.1002\/ijc.22104 author reply 2244","journal-title":"Int J Cancer"},{"key":"3252_CR27","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1158\/1055-9965.EPI-07-0555","volume":"17","author":"E B\u00e5geman","year":"2008","unstructured":"B\u00e5geman E, Ingvar C, Rose C, Jernstr\u00f6m H (2008) Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status. Cancer Epidemiol Biomark Prev 17:895\u2013901. doi: 10.1158\/1055-9965.EPI-07-0555","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3252_CR28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/2193-1801-3-261","volume":"3","author":"M Simonsson","year":"2014","unstructured":"Simonsson M, Markkula A, Bendahl PO, Rose C, Ingvar C, Jernstr\u00f6m H (2014) Pre-and postoperative alcohol consumption in breast cancer patients: impact on early events. SpringerPlus 3:261. doi: 10.1186\/2193-1801-3-261","journal-title":"SpringerPlus"},{"key":"3252_CR29","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1002\/ijc.28831","volume":"135","author":"A Markkula","year":"2014","unstructured":"Markkula A, Simonsson M, Rosendahl AH, Gaber A, Ingvar C, Rose C, Jernstr\u00f6m H (2014) Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients. Int J Cancer J Int Du Cancer 135:1898\u20131910. doi: 10.1002\/ijc.28831","journal-title":"Int J Cancer J Int Du Cancer"},{"key":"3252_CR30","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/bjc.2011.441","volume":"105","author":"KB Lundin","year":"2011","unstructured":"Lundin KB, Henningson M, Hietala M, Ingvar C, Rose C, Jernstr\u00f6m H (2011) Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients. Br J Cancer 105:1676\u20131683. doi: 10.1038\/bjc.2011.441","journal-title":"Br J Cancer"},{"key":"3252_CR31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/oxfordjournals.epirev.a018000","volume":"21","author":"JD Sorkin","year":"1999","unstructured":"Sorkin JD, Muller DC, Andres R (1999) Longitudinal change in the heights of men and women: consequential effects on body mass index. Epidemiol Rev 21:247\u2013260","journal-title":"Epidemiol Rev"},{"key":"3252_CR32","first-page":"18","volume":"75","author":"AL Hoe","year":"1993","unstructured":"Hoe AL, Mullee MA, Royle GT, Guyer PB, Taylor I (1993) Breast size and prognosis in early breast cancer. Ann R Coll Surg Engl 75:18\u201322","journal-title":"Ann R Coll Surg Engl"},{"key":"3252_CR33","doi-asserted-by":"crossref","first-page":"e932","DOI":"10.1542\/peds.2008-2491","volume":"123","author":"L Aksglaede","year":"2009","unstructured":"Aksglaede L, S\u00f8rensen K, Petersen JH, Skakkebaek NE, Juul A (2009) Recent decline in age at breast development: the Copenhagen Puberty Study. Pediatrics 123:e932\u2013e939. doi: 10.1542\/peds.2008-2491","journal-title":"Pediatrics"},{"key":"3252_CR34","unstructured":"Statens folkh\u00e4lsoinstitut Socialstyrelsen (2012) Folkh\u00e4lsan i Sverige, \u00e5rsrapport 2012 (Health in Sweden, The National Public Health Report 2012). http:\/\/www.socialstyrelsen.se\/ . http:\/\/www.socialstyrelsen.se\/Lists\/Artikelkatalog\/Attachments\/18623\/2012-3-6.pdf . Accessed 23 Sep 2014"},{"key":"3252_CR35","unstructured":"Statistics Sweden Unit of Social Welfare (2007) Use of alcohol and tobacco-Living Conditions. Report No. 114. http:\/\/www.scb.se\/ . http:\/\/www.scb.se\/statistik\/_publikationer\/LE0101_2004I05_BR_LE114SA0701.pdf . Accessed 21 May 2012"},{"key":"3252_CR36","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.breast.2011.04.010","volume":"20","author":"AK Baumgartner","year":"2011","unstructured":"Baumgartner AK, Hausler A, Seifert-Klauss V, Schuster T, Schwarz-Boeger U, Kiechle M (2011) Breast cancer after hormone replacement therapy\u2013does prognosis differ in perimenopausal and postmenopausal women? Breast 20:448\u2013454. doi: 10.1016\/j.breast.2011.04.010","journal-title":"Breast"},{"key":"3252_CR37","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/sj.bjc.6690543","volume":"80","author":"H Jernstr\u00f6m","year":"1999","unstructured":"Jernstr\u00f6m H, Frenander J, Fern\u00f6 M, Olsson H (1999) Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients. Br J Cancer 80:1453\u20131458. doi: 10.1038\/sj.bjc.6690543","journal-title":"Br J Cancer"},{"key":"3252_CR38","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/jnci\/djt043","volume":"105","author":"RT Chlebowski","year":"2013","unstructured":"Chlebowski RT, Manson JE, Anderson GL, Cauley JA, Aragaki AK, Stefanick ML, Lane DS, Johnson KC, Wactawski-Wende J, Chen C, Qi L, Yasmeen S, Newcomb PA, Prentice RL (2013) Estrogen plus progestin and breast cancer incidence and mortality in the women\u2019s health initiative observational study. J Natl Cancer Inst 105:526\u2013535. doi: 10.1093\/jnci\/djt043","journal-title":"J Natl Cancer Inst"},{"key":"3252_CR39","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00008469-199708000-00004","volume":"6","author":"H Jernstr\u00f6m","year":"1997","unstructured":"Jernstr\u00f6m H, Olsson H, Borg \u00c5 (1997) Reduced testosterone, 17 beta-oestradiol and sexual hormone binding globulin, and increased insulin-like growth factor-1 concentrations, in healthy nulligravid women aged 19\u201325\u00a0years who were first and\/or second degree relatives to breast cancer patients. Eur J Cancer Prev 6:330\u2013340","journal-title":"Eur J Cancer Prev"},{"key":"3252_CR40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000292493","volume":"38","author":"H Jernstr\u00f6m","year":"1994","unstructured":"Jernstr\u00f6m H, Olsson H (1994) Suppression of plasma insulin-like growth factor-1 levels in healthy, nulliparous, young women using low dose oral contraceptives. Gynecol Obstet Invest 38:261\u2013265","journal-title":"Gynecol Obstet Invest"},{"key":"3252_CR41","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/sj.bjc.6602389","volume":"92","author":"H Jernstr\u00f6m","year":"2005","unstructured":"Jernstr\u00f6m H, Sandberg T, B\u00e5geman E, Borg \u00c5, Olsson H (2005) Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families. Br J Cancer 92:857\u2013866. doi: 10.1038\/sj.bjc.6602389","journal-title":"Br J Cancer"},{"key":"3252_CR42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/humrep\/del318","volume":"22","author":"M Hietala","year":"2007","unstructured":"Hietala M, Sandberg T, Borg \u00c5, Olsson H, Jernstr\u00f6m H (2007) Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women. Hum Reprod 22:83\u201391. doi: 10.1093\/humrep\/del318","journal-title":"Hum Reprod"},{"key":"3252_CR43","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.amjsurg.2006.06.018","volume":"192","author":"JR Garreau","year":"2006","unstructured":"Garreau JR, Delamelena T, Walts D, Karamlou K, Johnson N (2006) Side effects of aromatase inhibitors versus tamoxifen: the patients\u2019 perspective. Am J Surg 192:496\u2013498. doi: 10.1016\/j.amjsurg.2006.06.018","journal-title":"Am J Surg"},{"key":"3252_CR44","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1200\/JCO.2003.04.024","volume":"21","author":"M Nystedt","year":"2003","unstructured":"Nystedt M, Berglund G, Bolund C, Fornander T, Rutqvist LE (2003) Side effects of adjuvant endocrine treatment in premenopausal breast cancer patients: a prospective randomized study. J Clin Oncol 21:1836\u20131844. doi: 10.1200\/JCO.2003.04.024","journal-title":"J Clin Oncol"},{"key":"3252_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.steroids.2011.10.002","volume":"77","author":"J Kotsopoulos","year":"2012","unstructured":"Kotsopoulos J, Narod SA (2012) Androgens and breast cancer. Steroids 77:1\u20139. doi: 10.1016\/j.steroids.2011.10.002","journal-title":"Steroids"},{"key":"3252_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-013-2505-2","volume":"139","author":"C Campagnoli","year":"2013","unstructured":"Campagnoli C, Pasanisi P, Castellano I, Abba C, Brucato T, Berrino F (2013) Postmenopausal breast cancer, androgens, and aromatase inhibitors. Breast Cancer Res Treat 139:1\u201311. doi: 10.1007\/s10549-013-2505-2","journal-title":"Breast Cancer Res Treat"},{"key":"3252_CR47","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.1158\/0008-5472.CAN-11-1080","volume":"71","author":"X Hou","year":"2011","unstructured":"Hou X, Huang F, Macedo LF, Harrington SC, Reeves KA, Greer A, Finckenstein FG, Brodie A, Gottardis MM, Carboni JM, Haluska P (2011) Dual IGF-1R\/InsR inhibitor BMS-754807 synergizes with hormonal agents in treatment of estrogen-dependent breast cancer. Cancer Res 71:7597\u20137607. doi: 10.1158\/0008-5472.CAN-11-1080","journal-title":"Cancer Res"},{"key":"3252_CR48","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1200\/JCO.1996.14.10.2738","volume":"14","author":"T Saphner","year":"1996","unstructured":"Saphner T, Tormey DC, Gray R (1996) Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 14:2738\u20132746","journal-title":"J Clin Oncol"},{"key":"3252_CR49","first-page":"416","volume":"55","author":"C Grasic-Kuhar","year":"2008","unstructured":"Grasic-Kuhar C, Bracko M, Zakotnik B (2008) Risk factors for late relapse and death in patients with early breast cancer. Neoplasma 55:416\u2013420","journal-title":"Neoplasma"},{"key":"3252_CR50","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1158\/1940-6207.CAPR-11-0442","volume":"5","author":"A Markkula","year":"2012","unstructured":"Markkula A, Hietala M, Henningson M, Ingvar C, Rose C, Jernstr\u00f6m H (2012) Clinical profiles predict early nonadherence to adjuvant endocrine treatment in a prospective breast cancer cohort. Cancer Prev Res 5:735\u2013745. doi: 10.1158\/1940-6207.CAPR-11-0442","journal-title":"Cancer Prev Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-3252-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-014-3252-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-3252-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T10:00:35Z","timestamp":1690797635000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-014-3252-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["3252"],"URL":"https:\/\/doi.org\/10.1007\/s10549-014-3252-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}